Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Many skin patients also have mental health issues, and doctors should treat both together.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.